Junshi narrows its losses but delivers no cure for share price woes
The drug maker boosted sales of its core anti-cancer product in the first half of the year and reined in its research budget under a reform-minded CEO, but revenue momentum…
Recent Articles
Junshi narrows its losses but delivers no cure for share price woes
1877.HK
688180.SHG
